merantix
A senior scientific leader will own the end‑to‑end clinical and scientific narrative for a deep‑tech photonic bio‑sensing startup, shaping biomarker strategy, clinical partnerships, assay development, regulatory pathways and advisory board activities. The role combines deep translational experience with hands‑on assay design to drive the company’s scientific roadmap and clinical validation.
Merantix is a Berlin‑based AI group that researches, builds, invests in, and connects companies to drive impactful AI made in Europe. It incubates and spins out AI startups, provides product and go‑to‑market support through its solutions arm (Merantix Momentum), and invests via Merantix Capital. The group also runs community and talent initiatives—including the Merantix AI Campus, AI hubs, and events—to grow networks, talent, and real‑world adoption. Merantix positions itself as an ecosystem operator combining research, venture building, and capital to scale applied AI across industries.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for merantix.
merantix didn’t post a salary, so this is our estimate from similar listings.
20% below the average for this role
Principal Scientist, Biomarker Operations Project Management
MSD
Sr. Scientist, Translational Medicine
RayzeBio
Director, Oncology Translational Research
lifelancer
Associate Director/Director, Global Biomarker Lead (GBL), Inflammation, ED&B GI2 TAU
Takeda Pharmaceutical Company Limited
Associate Director, Clinical Biomarker Development
Revolution Medicines
Director, Oncology Early Translational Biomarkers
GSK plc